Revised Title: Life Science Reit Reduces Dividend Due to Economic Uncertainties Impacting Rollout

Life Science Reit (LABS) has announced a reduction in dividends for 2023, with the payment per share dropping to 2p from 3p for the second half of the year. In its annual results for the year ending on December 31, the £284m property fund highlighted the challenges it faced due to economic uncertainty, occupiers delaying rental decisions, and high interest rates. As a result, the decision was made to cut dividends to ensure they were covered by earnings and could grow sustainably in the future.

Despite these challenges, LABS reported good progress during the 12-month period and emphasized the importance of rebasing dividends to maintain financial stability. The fund acknowledged that this was a difficult decision but one that was necessary to align with its strategy and provide additional financial flexibility. By reducing dividends, LABS aims to continue delivering on its objectives and position itself for future growth.

Overall, LABS remains focused on navigating current market conditions and optimizing its portfolio to maintain a strong financial position. With revised dividend payments, the fund is confident in its ability to adapt to challenges and capitalize on opportunities in the life sciences real estate sector.

By Aiden Johnson

As a content writer at, I have a passion for crafting engaging and informative articles that captivate readers. With a keen eye for detail and a knack for storytelling, I strive to deliver content that not only informs but also entertains. My goal is to create compelling narratives that resonate with our audience and keep them coming back for more. Whether I'm delving into the latest news topics or exploring in-depth features, I am dedicated to producing high-quality content that informs, inspires, and sparks curiosity.

Leave a Reply